Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Evans

Showing results (111-120 of 752) with videos related to

Pageof 76
Sort By:
International Journal of Surgical Pathology|July 28, 2011
Two out of three required: a case of incomplete Carney triadFinbar Slevin, Patricia Duncan, Patrick Shenjere, et al.
Theriogenology|September 6, 2005
In vitro and in vivo developmental capabilities and kinetics of in vitro development of in vitro matured oocytes from adult, unstimulated and hormone-stimulated prepubertal ewesKatherine M Morton, Sally L Catt, W M Chis Maxwell, et al.
BMC Neuroscience|April 17, 2013
RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulationAlejandro Dau, Pragya Komal, Mimi Truong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Familial ovarian cancer screeningDiane Stirling, Mary E Porteous, D Gareth Evans, et al.
European Journal of Human Genetics : EJHG|August 15, 2020
Reply to Kratz et alThierry Frebourg, Svetlana Bajalica Lagercrantz, Carla Oliveira, et al.
Journal of Medical Genetics|May 18, 2010
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovariesD Gareth Evans, Munaza Ahmed, Stuart Bayliss, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 10, 2007
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49Richard P A Norman, D Gareth Evans, Douglas F Easton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
BRCA1 and BRCA2 cancer risksAntonis C Antoniou, Paul D P Pharoah, Douglas F Easton, et al.
Journal of Clinical Medicine|June 18, 2020
Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial CancerNeil Aj Ryan, Louise Donnelly, Katie Stocking, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variantsNicola Flaum, Emma J Crosbie, Emma R Woodward, et al.
Pageof 76

Showing results (111-120 of 752) with videos related to

Sort By:
Pageof 76
International Journal of Surgical Pathology|July 28, 2011
Two out of three required: a case of incomplete Carney triadFinbar Slevin, Patricia Duncan, Patrick Shenjere, et al.
Theriogenology|September 6, 2005
In vitro and in vivo developmental capabilities and kinetics of in vitro development of in vitro matured oocytes from adult, unstimulated and hormone-stimulated prepubertal ewesKatherine M Morton, Sally L Catt, W M Chis Maxwell, et al.
BMC Neuroscience|April 17, 2013
RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulationAlejandro Dau, Pragya Komal, Mimi Truong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Familial ovarian cancer screeningDiane Stirling, Mary E Porteous, D Gareth Evans, et al.
European Journal of Human Genetics : EJHG|August 15, 2020
Reply to Kratz et alThierry Frebourg, Svetlana Bajalica Lagercrantz, Carla Oliveira, et al.
Journal of Medical Genetics|May 18, 2010
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovariesD Gareth Evans, Munaza Ahmed, Stuart Bayliss, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 10, 2007
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49Richard P A Norman, D Gareth Evans, Douglas F Easton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
BRCA1 and BRCA2 cancer risksAntonis C Antoniou, Paul D P Pharoah, Douglas F Easton, et al.
Journal of Clinical Medicine|June 18, 2020
Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial CancerNeil Aj Ryan, Louise Donnelly, Katie Stocking, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variantsNicola Flaum, Emma J Crosbie, Emma R Woodward, et al.
Pageof 76